Replies to post #332480 on Avid Bioservices Inc (CDMO)

[eb0783]

Cheynew, Here are a few paragraphs from the transcript that add a little more light on your capacity question.

I will now address the opportunities represented by the new client prospects mentioned above. First, these new projects are diverse ranging from customers interested in Avid’s development and early phase manufacturing experience to interest in our late phase and commercial experience, including access to the space we have for expansions to meet their future commercial demand.
I'm also pleased to announce the forward movement and execution of new business opportunities with our existing clients. We are currently expanding work that will result in the advancement of existing projects to the next phase of manufacturer, progressing molecules from smaller scale manufacturers to our larger 2,000-liter scale in Myford and increasing batch numbers.
In an earlier earnings call we announced supporting other clients with their process validation activities. Recent completion of these activities will enable certain clients to submit their biologics license application filings which will trigger the scheduling of future pre-approval inspections estimated to occur within the next two years related to the anticipated approval of these particular molecules.

….In terms of our other major clients, as Tracy noted, we've had a number of them go through the scale up for their commercial production and just waiting to see how those timelines develop, but that's all very positive for us in terms of future commercial work. So the trends are very positive right now in the biotech industry in general, and we're very, very fortunate that the number of our clients are expanding their programs and are very, very healthy at this point.